STOCK TITAN

Twist Bioscience Stock Price, News & Analysis

TWST Nasdaq

Welcome to our dedicated page for Twist Bioscience news (Ticker: TWST), a resource for investors and traders seeking the latest updates and insights on Twist Bioscience stock.

Twist Bioscience Corporation (TWST) is a leader in synthetic DNA production, utilizing a proprietary semiconductor-based platform to drive innovations across biotechnology and healthcare. This page provides investors and industry professionals with timely, accurate updates on TWST's strategic developments and operational milestones.

Access consolidated press releases and news covering earnings announcements, product launches, research breakthroughs, and partnerships. Our curated updates ensure you stay informed about TWST's advancements in gene synthesis, high-throughput manufacturing, and applications in precision medicine.

Key content includes quarterly financial results, regulatory filings, technology patents, and collaborations with academic or industry partners. All materials are sourced directly from verified company communications to maintain factual integrity.

Bookmark this page for streamlined access to TWST's evolving role in synthetic biology. Check regularly for critical updates impacting market positioning and technological leadership in DNA synthesis.

Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, has announced its executives' participation in upcoming investor conferences.

The schedule includes:

  • Emily Leproust, Ph.D., CEO and co-founder, and Adam Laponis, CFO, at the TD Cowen 45th Annual Health Care Conference on March 4 in Boston (fireside chat at 1:50 pm ET)
  • Patrick Finn, Ph.D., president and COO, and Adam Laponis, CFO, at the Leerink Global Biopharma Conference 2025 on March 11 in Miami (fireside chat at 9:20 am ET)
  • Patrick Finn and Adam Laponis at the Barclays Global Healthcare Conference 2025 on March 12 in Miami (fireside chat at 8:30 am ET)

All fireside chats will be webcast live through the investor relations section of the company's website and archived for 30 days after the events.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.95%
Tags
conferences
-
Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST) has announced the granting of 123,024 equity awards to 32 newly hired employees as employment inducements. The awards consist of 72,394 restricted stock units (RSUs) and up to 50,630 performance stock units (PSUs).

The RSUs will vest over 48 months, with 25% vesting after one year and 1/16 vesting quarterly thereafter. The PSUs will vest based on performance metrics set by the Board's Compensation Committee, achievable by the end of fiscal 2027 at 50%-140% of target. Both are subject to continued employment.

These awards were granted under Twist's Amended and Restated Inducement Equity Incentive Plan, complying with Nasdaq Listing Rule 5635(c)(4) for new hires or those returning after non-employment periods.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.74%
Tags
none
-
Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST), a mid-cap life sciences company in the healthcare sector, has announced its financial results for the first quarter of fiscal 2025, which ended December 31, 2024. The company has scheduled a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss the results and provide a business update.

Participants interested in joining via telephone must register through the company's Investor Relations website. Detailed earnings report and investor presentation are available on the Events and Presentations page of Twist Bioscience's website. A webcast replay will be accessible for two weeks following the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.73%
Tags
Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST) has announced it will release its fiscal 2025 first quarter financial results for the period ended December 31, 2024, before market opening on February 3, 2025. The company will host a conference call and live audio webcast for analysts and investors at 8:00 AM Eastern Time on the same day.

Participants interested in joining via telephone must pre-register through the company's Investor Relations website. The financial results press release will be available on the company's website in the Investor Relations section. A webcast replay will be accessible for two weeks following the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.75%
Tags
conferences earnings
-
Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST), a mid-cap life sciences company, has announced that CEO and co-founder Emily M. Leproust, Ph.D. will deliver a presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for January 13, 2025, at 5:15 p.m. Pacific Time in San Francisco, California.

The event will be accessible via webcast through the company's investor relations website's 'Investor Calendar' section. Following the live presentation, a replay will remain available for 30 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
conferences
-
Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST) announced its financial results for Q4 and full year fiscal 2024 ended September 30, 2024. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss the results and provide a business update. Participants can access detailed earnings reports and investor presentations through the company's website. Those joining via telephone must register in advance to receive dial-in information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.31%
Tags
Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST), a synthetic DNA manufacturer, announced its participation in the 7th Annual Evercore HealthCONx Conference. CEO and co-founder Emily M. Leproust, Ph.D., along with CFO Adam Laponis, will engage in a fireside chat on December 3, 2024, at 10:00 a.m. Eastern Time in Coral Gables, Florida. The event will be accessible via live webcast through the company's investor relations website, with a replay available for 30 days after the presentation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.31%
Tags
conferences
-
Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST) has announced new equity awards as employment inducements under Nasdaq Rule 5635(c)(4). The company granted 110,300 restricted stock units (RSUs) to 43 new employees and up to 37,500 performance stock units (PSUs) to VP Colby Souders. The RSUs vest over 48 months, with 25% vesting after one year and 1/16 vesting quarterly thereafter. The PSUs vest based on performance metrics for FY2024-2026, with potential earnings of 80%-150% of target, subject to continued employment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
none
-
Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST) has launched the FlexPrep™ Ultra-High Throughput Library Preparation Kit, featuring proprietary Normalization by Ligation™ technology. The kit enables processing of thousands of samples at low cost, eliminating the need for upfront sample quantitation and allowing early sample pooling. Researchers can run up to 1,152 samples in a single 96-well plate, reducing consumables by 12x and pipette tips usage from 17,000 to under 4,000. The company is collaborating with Gencove to provide genomic analysis software, offering an end-to-end workflow solution for agricultural and population genomics applications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
none
Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST) has announced it will release its fiscal 2024 fourth quarter and full year financial results on November 18, 2024, before market opening. The company will host a conference call and live audio webcast for analysts and investors at 8:00 AM Eastern Time. Participants interested in joining via telephone must register through the company's Investor Relations website. A webcast replay will be available for two weeks following the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.07%
Tags
conferences earnings

FAQ

What is the current stock price of Twist Bioscience (TWST)?

The current stock price of Twist Bioscience (TWST) is $28.26 as of May 23, 2025.

What is the market cap of Twist Bioscience (TWST)?

The market cap of Twist Bioscience (TWST) is approximately 1.8B.
Twist Bioscience

Nasdaq:TWST

TWST Rankings

TWST Stock Data

1.80B
58.72M
2.16%
112.29%
15.59%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO